QGEN : Analysis & Opinions

  1. Recent Financials May Not Be Entirely Fair To Hologic

    May 8, 2013
    Macro pressures are outweighing solid internal progress at Hologic.
  2. Impressive 4Q for Qiagen - Analyst Blog

    January 30, 2013
    Qiagen NV (QGEN) reported earnings per share (EPS) of 16 cents in the fourth quarter of 2012, significantly up from the break-even ...
  3. Medtronic Ends SFA II Enrollment - Analyst Blog

    January 24, 2013
    Medtronic Inc. (MDT) has further strengthened its endovascular business. Recently, this leading medical devices company completed ...
  4. Qiagen Beats 2012 Placement Target - Analyst Blog

    January 15, 2013
    Qiagen (QGEN), a major provider of innovative technologies and products for pre-analytical sample preparation and molecular ...
  5. QIAGEN Inks Three New Deals - Analyst Blog

    January 10, 2013
    In a bid to enhance its Personalized Healthcare diagnostic pipeline, QIAGEN (QGEN) inked three new deals to include multiple ...
  6. Hologic Surpasses Estimates - Analyst Blog

    November 14, 2012
    Hologic (HOLX) reported net loss of $77.8 million or 29 cents per share in the fourth quarter of fiscal 2012 compared with ...
  7. Will It Be Even Harder For Life Tech To Muddle Through In 2013?

    November 5, 2012
    Life Tech has the right technology, but 2013 could be a challenging year for the sector.
  8. Dutch Approval for Hologic's HPV HR - Analyst Blog

    July 19, 2012
    Hologic (HOLX), a prominent player in the field of women's health, recently got the Netherlands Society for Pathology's ("NVVP") ...
  9. FDA Approves Qiagen's KRAS Test - Analyst Blog

    July 9, 2012
    Molecular diagnostics solutions provider, Qiagen (QGEN) recently got the nod of the U.S. Food and Drug Administration ("FDA") ...
  10. Medicine Gets Personalized

    June 28, 2012
    With our population continuing to age and grow, innovation in the healthcare sector will need to move just as fast. One such ...
  11. Recognition for Hologic's Selenia - Analyst Blog

    June 28, 2012
    In a major achievement, Hologic (HOLX), a prominent player in the field of women's health, has won an award for its Selenia ...
  12. The Zacks Analyst Blog Highlights: Time Warner Cable, Comcast, ...

    May 8, 2012
    For Immediate Release Chicago, IL - May 8, 2012 - Zacks.com announces the list of stocks featured in the Analyst Blog. ...
  13. Myriad Beats, Raises Guidance - Analyst Blog

    May 2, 2012
    Myriad Beats, Raises Guidance - Analyst Blog
  14. Is Hologic A Coiled Spring?

    November 11, 2011
    Hologic looks cheap on even modest growth recovery expectations.
  15. Becton Dickinson Moves The Bar Lower

    November 4, 2011
    Becton Dickinson is in a growth rut. Investors could be looking at a stagnant stock for a little while.
  16. R&D The Future For Life Sciences Equipment Firms

    September 20, 2011
    Finding new healthcare solutions will be a paramount concern going forward. For investors, the best way to profit from this ...
  17. Cepheid Soaring

    August 2, 2011
    Cepheid is becoming a real player in MDx, but the valuation is way ahead.
  18. Agri-Tech Heats Up

    May 4, 2011
    Just as technology has revolutionized the healthcare industry, agriculture is undergoing its own tech renaissance.
  19. Hologic Holding The Line

    May 4, 2011
    Hologic lacks exciting growth, but the technology is in place for better growth in the future.
  20. What Becton Dickinson Lacks In Flash, It Makes Up For In Quality

    April 28, 2011
    Becton Dickinson is a great company with improving prospects that is ideal for long-term investors.
  21. With Minimal Expectations, Hologic Could Still Surprise

    November 10, 2010
    Hologic is suffering from low expectations, but value investors may have a bargain here.
  22. Becton Dickinson More Interesting Than You Think

    May 3, 2010
    Becton Dickinson is often dismissed as "boring" but a diversified cash-generating business with real growth shouldn't be.
  23. Are These Stocks Takeover Targets?

    March 10, 2010
    It's a fool errand to buy stocks based solely on a potential buyout, but the search may lead to fruitful ideas.
Investing News
  1. 3 Dumb Ways to Borrow Money

    Money — everyone needs it, but not everyone has it. Many people who find themselves in a ...
  2. Infographic - The Lifecycle of a Bond

    Basic information on how Bonds work.
  3. What $200,000 Will Buy In The Atlanta Real Estate Market

    Atlanta housing prices are up from last year, but they're still lower than the national median. ...
  4. Bubble Bursting? Only For Biotech & Internet Stocks

    The recent sluggish performance of U.S. stocks is leading some market watchers to question ...
  5. What $300,000 Will Buy In The Riverside/San Bernardino Real Estate Market

    The median list price for the San Bernardino/Riverside, Calif. market is $292,800, up 24.6% ...
  6. What Is Worse Than Being At Risk?

    You may have heard the old adage: “What is worse than being lost? Not knowing you are lost.” ...
Trading Center